IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Tri Locum Partners LP

Q3 2023 Holdings

Filed 2023-11-14 | 61 holdings | $312.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↑Shares% Portfolio
GE Healthcare Technologies I(GEHC)COMMON STOCK36266G107$9.0M131,8102.9%
Axsome Therapeutics Inc(AXSM)COM05464T104$10.0M142,5103.2%
Avadel Pharmaceuticals PLCSPONSORED ADR05337M104$10.1M983,6023.2%
Natera Inc(NTRA)COM632307104$12.2M274,7953.9%
Catalent Inc(CTLTEUR)COM148806102$13.0M285,9994.2%
Regeneron Pharmaceuticals(REGN)COM75886F107$16.5M20,0095.3%
Spdr S&P 500 ETF TR(SPY)TR UNIT78462F103$19.3M45,2086.2%
Abbvie Inc(ABBV)COM00287Y109$21.5M144,5616.9%
Dexcom Inc(DXCM)COM252131107$24.9M267,3808.0%
Teva Pharmaceutical Inds LTD(TEVA)SPONSORED ADS881624209$26.9M2,632,8938.6%
Amgen Inc(AMGN)COM031162100$28.9M107,4809.2%
PreviousPage 2 of 2